Loading...
XNASICCM
Market cap60mUSD
Dec 24, Last price  
1.11USD
1D
-0.89%
1Q
83.50%
IPO
-89.82%
Name

Icecure Medical Ltd

Chart & Performance

D1W1MN
XNAS:ICCM chart
P/E
—
P/S
18.83
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
31.36%
Rev. gr., 5y
24.68%
Revenues
3m
+4.67%
354,6301,068,586762,873625,487689,3771,071,9021,657,6184,084,5264,138,0003,085,0003,229,000
Net income
-15m
L-14.90%
00000000-10,066,000-17,217,000-14,652,000
CFO
-13m
L-12.39%
00000000-12,605,000-14,292,000-12,521,000

Profile

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
URL
https://icecure-medical.com/
IPO date
Feb 02, 2011
Employees
65
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
3,229
4.67%
3,085
-25.45%
4,138
1.31%
Cost of revenue
18,805
19,824
13,862
Unusual Expense (Income)
NOPBT
(15,576)
(16,739)
(9,724)
NOPBT Margin
Operating Taxes
239
171
Tax Rate
NOPAT
(15,576)
(16,978)
(9,895)
Net income
(14,652)
-14.90%
(17,217)
71.04%
(10,066)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
84
13,575
30,552
BB yield
Debt
Debt current
223
167
224
Long-term debt
975
1,027
1,594
Deferred revenue
Other long-term liabilities
618
Net debt
(9,864)
(22,465)
(23,803)
Cash flow
Cash from operating activities
(12,521)
(14,292)
(12,605)
CAPEX
(480)
(891)
(533)
Cash from investing activities
(713)
(891)
3,792
Cash from financing activities
83
13,577
30,889
FCF
(14,202)
(18,013)
(11,804)
Balance
Cash
11,062
23,659
25,621
Long term investments
Excess cash
10,901
23,505
25,414
Stockholders' equity
(90,061)
(75,409)
(58,431)
Invested Capital
102,823
101,428
86,916
ROIC
ROCE
EV
Common stock shares outstanding
45,638
37,017
28,549
Price
Market cap
EV
EBITDA
(15,253)
(16,491)
(9,597)
EV/EBITDA
Interest
239
Interest/NOPBT